Calls for industry transparency increasing
Transparency will be a huge frontier for pharmaceutical companies during the next three to four years. John T. Bentivoglio, JD, cochair of King & Spaulding’s FDA/Healthcare Practice in Washington, DC, says he can’t overemphasize the importance of transparency.
Most Viewed
Most Emailed
- ICD-10 Coding Uncovers Higher Rate of Fatal Falls Among Seniors
- Mapping Out Revenue-Cycle Solutions
- Will Maryland's Rate Shift Send Tremors Around the Country?
- MO Hospitals Review Highlights Value of Disaster Preparedness
- E-book Revolution Changes, Challenges Healthcare
- Medical Boards Step Up Disciplinary Actions
- Best Healthcare Leaders Know When to Exit
- FL Hospital Vendors Sentenced in Bribery Scheme
- Aetna Building National ACO Network
- How Rivals Built an ACO

